Aflac Incorporated (NYSE:AFL) Shares Sold by Envestnet Asset Management Inc.

Envestnet Asset Management Inc. lowered its position in shares of Aflac Incorporated (NYSE:AFL - Free Report) by 33.9% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 802,709 shares of the financial services provider's stock after selling 412,133 shares during the quarter. Envestnet Asset Management Inc. owned 0.14% of Aflac worth $83,032,000 as of its most recent SEC filing.

Other hedge funds have also modified their holdings of the company. Grantham Mayo Van Otterloo & Co. LLC increased its stake in Aflac by 629.3% in the 4th quarter. Grantham Mayo Van Otterloo & Co. LLC now owns 61,680 shares of the financial services provider's stock worth $6,380,000 after buying an additional 53,223 shares in the last quarter. Aviva PLC increased its holdings in shares of Aflac by 22.5% in the fourth quarter. Aviva PLC now owns 321,523 shares of the financial services provider's stock worth $33,258,000 after purchasing an additional 59,080 shares during the last quarter. Resona Asset Management Co. Ltd. purchased a new position in Aflac during the 4th quarter valued at approximately $17,843,000. Unison Advisors LLC boosted its position in shares of Aflac by 0.4% during the 4th quarter. Unison Advisors LLC now owns 45,764 shares of the financial services provider's stock valued at $4,734,000 after acquiring an additional 201 shares during the last quarter. Finally, Yoffe Investment Management LLC bought a new position in Aflac during the fourth quarter valued at $465,000. 67.44% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Several brokerages have recently weighed in on AFL. JPMorgan Chase & Co. increased their price target on Aflac from $94.00 to $96.00 and gave the stock a "neutral" rating in a report on Wednesday, April 2nd. StockNews.com upgraded Aflac from a "sell" rating to a "hold" rating in a report on Friday, February 14th. Piper Sandler raised their price target on Aflac from $118.00 to $124.00 and gave the company an "overweight" rating in a research note on Wednesday, April 2nd. Barclays decreased their price objective on Aflac from $98.00 to $95.00 and set an "underweight" rating for the company in a report on Friday, February 7th. Finally, UBS Group increased their target price on shares of Aflac from $109.00 to $114.00 and gave the stock a "neutral" rating in a report on Wednesday, April 2nd. Two research analysts have rated the stock with a sell rating, eleven have issued a hold rating and two have assigned a buy rating to the company's stock. According to MarketBeat.com, the company presently has a consensus rating of "Hold" and a consensus target price of $103.93.

Remove Ads

Insider Activity at Aflac

In other news, Director Charles D. Lake II sold 29,802 shares of the business's stock in a transaction on Monday, March 10th. The shares were sold at an average price of $107.29, for a total transaction of $3,197,456.58. Following the sale, the director now directly owns 49,962 shares of the company's stock, valued at $5,360,422.98. The trade was a 37.36 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Joseph L. Moskowitz sold 1,000 shares of the firm's stock in a transaction on Friday, March 7th. The stock was sold at an average price of $107.63, for a total value of $107,630.00. Following the completion of the transaction, the director now owns 25,393 shares of the company's stock, valued at $2,733,048.59. This trade represents a 3.79 % decrease in their position. The disclosure for this sale can be found here. 0.90% of the stock is currently owned by insiders.

Aflac Stock Up 2.6 %

NYSE AFL traded up $2.75 on Monday, hitting $109.58. The stock had a trading volume of 293,907 shares, compared to its average volume of 2,004,819. The business's fifty day moving average price is $106.34 and its 200 day moving average price is $107.41. The stock has a market cap of $59.81 billion, a price-to-earnings ratio of 11.41, a price-to-earnings-growth ratio of 3.24 and a beta of 0.81. The company has a debt-to-equity ratio of 0.29, a current ratio of 0.10 and a quick ratio of 0.08. Aflac Incorporated has a 52-week low of $79.69 and a 52-week high of $115.50.

Aflac (NYSE:AFL - Get Free Report) last announced its earnings results on Wednesday, February 5th. The financial services provider reported $1.56 earnings per share for the quarter, missing the consensus estimate of $1.63 by ($0.07). Aflac had a return on equity of 16.20% and a net margin of 28.76%. Equities research analysts anticipate that Aflac Incorporated will post 6.88 earnings per share for the current year.

Aflac Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.